S. Boccuzzi

发表

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.

Sidney C. Smith, S. Smith, C. Sueta, 1999, The American journal of cardiology.

Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy.

D. Waters, L. Higginson, J. Lespérance, 1995, Circulation.

Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial.

C. Cannon, H. Krumholz, J. Spertus, 1999, The American journal of cardiology.

Resource use associated with topiramate in migraine prophylaxis.

A. Blount, M. Rupnow, S. Boccuzzi, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

DILITIZEM INCREASES LATE-ONSET CONGESTIVE HEART FAILURE IN POSTINFARCTION PATIENTS WITH EARLY REDUCTION IN EJECTION FRACTION

S. Nattel, R. Goldstein, D. Cruess, 1991 .

Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Angiotensin-converting enzyme inhibitors in the management of congestive heart failure: a pharmaceutical industry perspective.

S. Boccuzzi, 1999, American Heart Journal.

Economic winners and losers after introduction of an effective new therapy depend on the type of payment system.

W. Weintraub, A. Kosinski, E. Becker, 1997, The American journal of managed care.

Indirect Health Care Costs

S. Boccuzzi, 2003 .

Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial).

W. Weintraub, A. Kosinski, S. Boccuzzi, 1998, The American journal of cardiology.

Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group.

D. Waters, L. Higginson, P. Gladstone, 1996, Circulation.

Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.

W. Herman, J. Kjekshus, T. Pedersen, 1999, Diabetes care.

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.

S. Nattel, R. Goldstein, D. Cruess, 1991, Circulation.

Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.

W. Weintraub, A. Kosinski, D. Cohen, 1999, Journal of the American College of Cardiology.

Adherence to Prescribed Treatment for Asthma: Evidence from Pharmacy Benefits Data

N. Santanello, P. Strub, Craig A. Jones, 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome.

Jay Lin, S. Boccuzzi, A. L. Feliu, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Serial acquisition of data to predict one-year mortality rate after acute myocardial infarction.

T. Therneau, R. Goldstein, S. Boccuzzi, 1987, The American journal of cardiology.

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

W. Weintraub, A. Kosinski, R. Alexander, 1995, The New England journal of medicine.

Noninvasive and angiographic evaluation of coronary artery disease in patients with peripheral vascular disease.

H. L. Price, S. Boccuzzi, D. Youngman, 1989, The American journal of cardiology.

Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.

W. O’Neill, W. Weintraub, A. Kosinski, 1994, The New England journal of medicine.

Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed

J. Stephenson, John Martin, S. Boccuzzi, 2009, Current medical research and opinion.

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

S. Haffner, J. Kjekshus, T. Pedersen, 1999, Archives of internal medicine.